Skip to main content

Advertisement

Log in

Oxaliplatin pharmacokinetics on hemodialysis in a patient with diffuse large B cell lymphoma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Stein A, Arnold D (2012) Oxaliplatin: a review of approved uses. Expert Opin Pharmacother 13(1):125–137. doi:10.1517/14656566.2012.643870

    Article  CAS  PubMed  Google Scholar 

  2. Takimoto CH, Graham MA, Lockwood G, Ng CM, Goetz A, Greenslade D, Remick SC, Sharma S, Mani S, Ramanathan RK, Synold TW, Doroshow JH, Hamilton A, Mulkerin DL, Ivy P, Egorin MJ, Grem JL (2007) Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function. Clin Cancer Res 13(16):4832–4839. doi:10.1158/1078-0432.CCR-07-0475

    Article  CAS  PubMed  Google Scholar 

  3. Horimatsu T, Miyamoto S, Morita S, Mashimo Y, Ezoe Y, Muto M, Chiba T (2011) Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy. Cancer Chemother Pharmacol 68(1):263–266. doi:10.1007/s00280-011-1633-9

    Article  CAS  PubMed  Google Scholar 

  4. Gori S, Lunardi G, Inno A, Magarotto R, Duranti S, Messa MG, Mucchino C, Cirillo M (2014) Pharmacokinetics of oxaliplatin in a hemodialyzed patient: chemotherapy dose adjustment and timing of dialysis. Clin Colorectal Cancer 13(4):260–263. doi:10.1016/j.clcc.2014.09.003

    Article  PubMed  Google Scholar 

  5. Delord JP, Umlil A, Guimbaud R, Gregoire N, Lafont T, Canal P, Bugat R, Chatelut E (2003) Population pharmacokinetics of oxaliplatin. Cancer Chemother Pharmacol 51(2):127–131. doi:10.1007/s00280-002-0550-3

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael S. Balzer.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from the patient described.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Balzer, M.S., Eggers, H., Heuser, M. et al. Oxaliplatin pharmacokinetics on hemodialysis in a patient with diffuse large B cell lymphoma. Ann Hematol 95, 649–650 (2016). https://doi.org/10.1007/s00277-016-2607-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2607-0

Keywords

Navigation